Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Liver Transplantation Following Organ Donation After Medical Assistance in Dying: One Step Further.

Transplantation·2026
Same author

Metformin suppresses β-cell apoptosis under ER stress by inhibiting protein translation.

Metabolism: clinical and experimental·2026
Same author

Pretransplant aerobic exercise improves glycemic outcomes after marginal islet mass transplantation in rats.

American journal of physiology. Endocrinology and metabolism·2026
Same author

RIP kinase inhibition with Necrostatin-1 improves human marginal mass islet graft survival and function for the management of type 1 diabetes.

Cell death & disease·2026
Same author

Correction: Extracellular Matrix-Guided Islet Cell Transplantation Results in Improved Glycemic Control in a NOD-SCID Mouse Model.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2026
Same author

Autologous and allogeneic stem cell-derived islet therapy in three recipients with type 1 diabetes and complete loss of endogenous pancreatic β-cell function pretransplant.

The lancet. Diabetes & endocrinology·2026

Related Experiment Video

Updated: Sep 21, 2025

Author Spotlight: Advancements and Challenges in β-Cells Differentiation from Pluripotent Stem Cells
06:33

Author Spotlight: Advancements and Challenges in β-Cells Differentiation from Pluripotent Stem Cells

Published on: February 2, 2024

2.1K

Optimizing Generation of Stem Cell-Derived Islet Cells.

Kevin Verhoeff1,2, Nerea Cuesta-Gomez1,2, Ila Jasra1,2

  • 1Department of Surgery, University of Alberta, Edmonton, Alberta, Canada.

Stem Cell Reviews and Reports
|May 31, 2022
PubMed
Summary
This summary is machine-generated.

Stem cell therapy offers new hope for type 1 diabetes treatment, moving towards patient-specific islet cell regeneration. This review details differentiation protocols to advance regenerative cell therapies safely and effectively.

Keywords:
DiabetesDifferentiationInducible pluripotent stem cellsIslet cell transplant

More Related Videos

Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters
08:41

Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters

Published on: June 23, 2023

3.3K
Generation of Scaffold-free, Three-dimensional Insulin Expressing Pancreatoids from Mouse Pancreatic Progenitors In Vitro
09:33

Generation of Scaffold-free, Three-dimensional Insulin Expressing Pancreatoids from Mouse Pancreatic Progenitors In Vitro

Published on: June 2, 2018

9.2K

Related Experiment Videos

Last Updated: Sep 21, 2025

Author Spotlight: Advancements and Challenges in β-Cells Differentiation from Pluripotent Stem Cells
06:33

Author Spotlight: Advancements and Challenges in β-Cells Differentiation from Pluripotent Stem Cells

Published on: February 2, 2024

2.1K
Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters
08:41

Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters

Published on: June 23, 2023

3.3K
Generation of Scaffold-free, Three-dimensional Insulin Expressing Pancreatoids from Mouse Pancreatic Progenitors In Vitro
09:33

Generation of Scaffold-free, Three-dimensional Insulin Expressing Pancreatoids from Mouse Pancreatic Progenitors In Vitro

Published on: June 2, 2018

9.2K

Area of Science:

  • Endocrinology
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Islet transplantation is effective for type 1 diabetes but limited by donor availability and immunosuppression.
  • Advancements in induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs) offer potential for autologous and allogeneic regenerative therapies.
  • Current limitations hinder widespread application of stem cell-derived islet therapies.

Purpose of the Study:

  • To review current protocols for differentiating stem cells into functional islet cells.
  • To provide a detailed breakdown of differentiation stages for controlled generation of islet products.
  • To guide the field toward safe, standardized, and efficient islet cell production.

Main Methods:

  • Review of existing scientific literature on stem cell differentiation protocols for islet generation.
  • Analysis of key stages in the differentiation process, from pluripotent cells to functional islets.
  • Discussion of strategies to optimize yield and minimize off-target cell growth.

Main Results:

  • Identification of critical factors and pathways influencing stem cell differentiation towards an islet fate.
  • Comparison of different differentiation strategies and their efficiencies.
  • Highlighting the need for standardized protocols to ensure safety and efficacy.

Conclusions:

  • Stem cell-derived islet therapies hold significant promise for treating type 1 diabetes.
  • Standardized and safe differentiation protocols are crucial for clinical translation.
  • Further research is needed to optimize yield and ensure the long-term function and safety of these regenerative cell products.